Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries.
Open accessAbstract
OBJECTIVE: Excess mortality from diseases and medical conditions (natural death) in persons with psychiatric disorders has been extensively reported. Even in the Nordic countries with well-developed welfare systems, register based studies find evidence of an excess mortality. In recent years, cardiac mortality and death by diseases of the circulatory system has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease. The aim of this study was to compare the mortality by diseases of the circulatory system among patients with bipolar disorder or schizophrenia in the three Nordic countries Denmark, Sweden, and Finland. Furthermore, the aim was to examine and compare life expectancy among these patients. Cause specific Standardized Mortality Rates (SMRs) were calculated for each specific subgroup of mortality. Life expectancy was calculated using Wiesler's method. RESULTS: The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes. SMR was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark. Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter. CONCLUSION: Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy. An evaluation of the reasons for these increased mortality rates should be prioritized when planning healthcare in the coming years.
AI snapshot
Written from the paper’s full text.
TL;DR
In Denmark, Finland, and Sweden, people hospitalized with bipolar disorder or schizophrenia had 2- to 3-fold overall mortality and substantially reduced life expectancy compared with the general population. Mortality from diseases of the circulatory system was about 2-fold elevated in bipolar disorder and somewhat higher in schizophrenia, except among men in Denmark.
Key findings
- Among 39,375 persons with bipolar disorder and 66,088 with schizophrenia followed in 2000–2006, all-cause SMRs were 2.0–2.8 for bipolar disorder and 2.9–3.9 for schizophrenia; for example, men in Finland had SMR 2.8 for bipolar disorder and 3.3 for schizophrenia, while women in Finland had SMR 2.5 and 3.9, respectively.
- SMRs for diseases of the circulatory system (DCS) in bipolar disorder were approximately 2 in all countries and both sexes, with overall DCS SMRs ranging from 1.7 to 2.2. In schizophrenia, overall DCS SMRs ranged from 1.8 to 2.9 and were higher than in bipolar disorder except for men in Denmark (1.8 vs 2.0).
- Life expectancy at age 15 was 11 to 20 years shorter overall. In the table, differences for men were 12.7–19.8 years for bipolar disorder and 17.1–20.0 years for schizophrenia; for women, differences were 11.0–16.2 years for bipolar disorder and 15.6–16.9 years for schizophrenia.
- During 2000–2006, 2,960 of 5,436 deaths (54%) in bipolar disorder and 6,424 of 9,535 deaths (67%) in schizophrenia would not have occurred if mortality matched the general population; 781 and 1,770 of these excess deaths were from DCS, and the total avoidable deaths across both groups were 9,384 over seven years.
Methods
- Register-based cohort study in Denmark, Finland, and Sweden including all persons with a psychiatric hospitalization with a main diagnosis of bipolar disorder or schizophrenia. Follow-up began on 1 January 2000 or the 15th birthday, whichever came last, and ended on 1 January 2007 or death, whichever came first.
- Diagnoses came from national psychiatric/hospital discharge registers using ICD-8, ICD-9, or ICD-10 as relevant; deaths came from national cause-of-death registers. Schizoaffective disorder was excluded from both diagnostic groups.
- Cause-specific SMRs were age-standardized to the Nordic standard population in 2000 with 95% confidence intervals; life expectancy at 15 was calculated using Wiesler’s method with one-year age stratification; avoidable deaths were calculated as N*((SMR−1)/SMR).
Limitations
- The paper states that schizoaffective disorder was excluded, that ICD diagnoses do not differentiate bipolar I from bipolar II disorder (so bipolar I may be overestimated), that antipsychotic treatment differences may partly explain cardiovascular mortality differences, and that Finland’s fragmented health care access may contribute to its higher SMRs.
- Evident from the text: the cohort includes only patients with a psychiatric hospitalization, so findings may not generalize to non-hospitalized or outpatient-treated patients.
- Evident from the text: register data lack individual confounders such as lifestyle, smoking, alcohol, exercise, and medication adherence; Swedish hospital data were incomplete before 1987, so case ascertainment relied on a 1987–1999 lookback.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 30 cited sources checked · 0 supported · 0 flagged
- Findingown data
The SMR for bipolar disorder for diseases of the circulatory system was lower than the all-cause SMRs.
“The SMR for bipolar disorder for different subgroups of diseases of the circulatory system (DCS) was approximately 2 in all countries and both sexes, and thus lower than the all-cause SMRs, Table 1and 2.”
Quote in the paperNot a substantial claim - Findingown data
The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes.
“The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes.”
- Also stated in: § Results · plain
“The SMR for bipolar disorder for different subgroups of diseases of the circulatory system (DCS) was approximately 2 in all countries and both sexes, and thus lower than the all-cause SMRs, Table 1and 2.”
Quote in the paperNot a substantial claim - Also stated in: § Results · plain
- Findingown data
In spite of recent focus on the excess mortality among persons with schizophrenia or bipolar disorder, persons with schizophrenia or bipolar disorder still have a substantially reduced life expectancy.
“this study show that persons with schizophrenia or bipolar disorder still have a substantially reduced life expectancy.”
Quote in the paperSubstantial claim - Findingown data
Apart from the difference in SMRs, mortality rates and life expectancy are remarkably similar in the three countries.
“Apart from this difference the mortality rates and life expectancy are remarkably similar in the three countries.”
Quote in the paperNot a substantial claim - Findingown data
Persons with bipolar disorder in Denmark and Sweden had higher life expectancy than persons with schizophrenia.
“Persons with bipolar disorder in Denmark and Sweden had higher life expectancy than persons with schizophrenia.”
Quote in the paperSubstantial claim- Rests on an assumption: The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
- Findingown data
Even in the Nordic countries with well-developed welfare and public health systems, this group of patients experiences an unacceptable high mortality.
“Even in the Nordic countries with well-developed welfare and public health systems this group of patients experiences an unacceptable high mortality.”
Quote in the paperSubstantial claim - Findingown data
Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter.
“Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter.”
- Also stated in: § Results · plain
“Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being 11 to 20 years shorter.”
- Also stated in: § Conclusion · plain
“Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy.”
Quote in the paperSubstantial claim- Rests on an assumption: The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
- Also stated in: § Results · plain
- Findingown data
SMR for mortality from external causes was very high, ranging from 4 to 10.
“In general SMR for mortality from external causes (accidents, suicide, and homicide) was very high (range from 4 to 10).”
Quote in the paperNot a substantial claim - Findingown data
If no excess mortality from external causes was present, the numbers was 865 and 1,322, respectively.
“If no excess mortality from external causes was present the numbers was 865 and 1,322, respectively.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
- Findingown data
The number of deaths in all three countries that would not have occurred if persons with bipolar disorder or schizophrenia had not had an excess mortality from I00-I99 was 781 and 1,770, respectively.
“The number of deaths in all three countries that would not have occurred if persons with bipolar disorder or schizophrenia had not had an excess mortality from I00-I99 was 781 and 1,770, respectively.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
- Findingown data
By reducing mortality in the group of persons with schizophrenia or bipolar disorder (approximately 100,000 persons) to the level of the general population, 9,384 deaths would have been avoided in the seven year period of this study in the three Nordic countries.
“By reducing mortality in the group of persons with schizophrenia or bipolar disorder (approximately 100,000 persons) to the level of the general population, 9,384 deaths would have been avoided in the seven year period of this study in the three Nordic countries.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
- Findingown data
SMRs for persons with bipolar disorder were lower compared to SMRs for schizophrenia in all three study countries.
“In this study SMRs for persons with bipolar disorder were lower compared to SMRs for schizophrenia in all three study countries.”
Quote in the paperSubstantial claim - Findingown data
SMR for diseases of the circulatory system was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark.
“SMR was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark.”
Quote in the paperNot a substantial claim - Findingown data
Overall mortality among persons with bipolar disorder or schizophrenia in the three Nordic countries increased 2- to 3-fold compared to the general population.
“we found that overall mortality increased 2- to 3-fold compared to the general population.”
Quote in the paperSubstantial claim - Findingown data
In Finland, persons with bipolar disorder had shorter life expectancy than persons with schizophrenia.
“This was in contrast to Finland where persons with bipolar disorder had shorter life expectancy, Table 3.”
Quote in the paperNot a substantial claim- Rests on an assumption: The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
- Findingown data
The same pattern of DCS subdivision SMRs was seen among persons with schizophrenia.
“The same pattern was seen among persons with schizophrenia.”
Quote in the paperNot a substantial claim - Findingown data
In Finland, SMR for death from external causes was generally higher in persons with bipolar disorder than in persons with schizophrenia.
“In Finland, SMR for death from external causes was in general higher in persons with bipolar disorder than in persons with schizophrenia, Table 1 and 2.”
Quote in the paperNot a substantial claim - Findingown data
Among persons with bipolar disorder or schizophrenia, life expectancy was generally 12 to 20 years reduced for men and 11 to 17 years reduced for women, compared to the general population.
“Among persons with bipolar disorder or schizophrenia, life expectancy was generally 12 to 20 years reduced for men and 11 to 17 years reduced for women, compared to the general population.”
Quote in the paperSubstantial claim - Findingown data
Life expectancy among persons with bipolar disorder and schizophrenia was higher in Sweden than in the other two Nordic countries.
“Similarly, life expectancy among persons with bipolar disorder and schizophrenia was higher in Sweden than in the other two Nordic countries.”
Quote in the paperNot a substantial claim- Rests on an assumption: The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
- Findingown data
In all other cases, the overall SMR for people with schizophrenia was significantly higher (no overlapping confidence intervals) than for bipolar disorder.
“In all other cases the overall SMR for people with schizophrenia was significantly higher (no overlapping confidence intervals) than for bipolar disorder.”
Quote in the paperSubstantial claim - Findingreasoning
SMRs had a tendency to be slightly higher in Finland.
“The SMRs had a tendency to be slightly higher in Finland.”
Quote in the paperNot a substantial claim - Findingown data
Only men in Finland with schizophrenia had overlapping confidence intervals of the overall SMR with men with bipolar disorder.
“as only men in Finland with schizophrenia had overlapping confidence intervals of the overall SMR with men with bipolar disorder.”
Quote in the paperSubstantial claim - Study design and conductcitation
The Swedish Hospital Discharge Register has a high level of completeness.
“The Swedish register has a high level of completeness [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] (2010) Socialstyrelsen.
Not checked in the free run.
- Study design and conductcitation
The Finnish Hospital Discharge Register (FHDR) has good validity.
“The validity of the FHDR has been found to be of good quality [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] I Keskimäki, 1991, The accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital Discharge Register, International Journal of Health Sciences
Not checked in the free run.
- Study design and conductcitation
The Finnish Cause of Death Register has excellent completeness because all diagnoses routinely pass validation by Statistics Finland.
“The completeness of the register is excellent since all diagnosis routinely passes a validation by Statistics Finland [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Lahti RA, Penttila A (2001) The validity of death certificates: routine validation of death certification and its effects on mortality statistics. Forensic Sci Int 115: 15–32. S0379-0738(00)00300-5 [pii]. source
Not checked in the free run.
- Premisecitation
Even in the Nordic countries with well-developed welfare systems, register based studies find continued evidence of an excess mortality.
“Even in the Nordic countries with well-developed welfare systems, register based studies find continued evidence of an excess mortality [2]–[7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2]–[7]
Not checked in the free run.
- Study design and conductcitation
The Danish Central Psychiatric Case Register has high validity.
“The validity of the register is high [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] K Juel, 1999, The Danish registers of causes of death, Dan Med Bull
Not checked in the free run.
- Premisecitation
Patients with bipolar disorder or schizophrenia seem to be a particular vulnerable patient group.
“Patients with bipolar disorder or schizophrenia seem to be a particular vulnerable patient group [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] TM Laursen, 2007, Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia, J Clin Psychiatry source
Not checked in the free run.
- Study design and conductcitation
Crude mortality rates were age-standardized using the Nordic standard population in 2000 to make reliable comparison of SMRs between countries.
“In order to make a reliable comparison of SMRs between the countries the crude mortality rates were age-standardized by using the Nordic standard population in 2000 [22].”
- Also stated in: § Statistical Analyses · plain
“we standardized the SMR in each of the three countries to the same age distribution to ensure that the differences in SMR was not merely due to differences in the age distribution in the three countries, see chapter 3 in Rothman et al. [23].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [22] NOMESCO (2009) Health Statistics in the Nordic Countries 2007. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nomesco-eng.nom-nos.dk/default.asp?side=189" xlink:type="simple">http://nomesco-eng.nom-nos.dk/default.asp?side=189</ext-link>. Accessed 2013 May 23.
Not checked in the free run.
- cites [23] Rothman KJ, Greenland S, Lash TL (2008) Measures of occurrence. In: Modern Epidemiology. Philadelphia: Wolters Kluwer. 32–51.
Not checked in the free run.
- Also stated in: § Statistical Analyses · plain
- Interpretationreasoning
The difference in antipsychotic treatment might at least partially explain the difference in cardiovascular mortality outcome found in this study.
“The difference in antipsychotic treatment might at least partially explain the difference in cardiovascular mortality outcome found in this study.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] M Adler, 2012, Symptoms and treatment of bipolar patients in Sweden, Int J Psychiatry Clin Pract source
Not checked in the free run.
- Study design and conductnone given
For the bipolar disorder sample, ICD diagnoses do not differentiate between bipolar I or bipolar II disorder.
“For the bipolar disorder sample, ICD diagnoses does not differentiate between bipolar I or bipolar II disorder.”
Quote in the paperSubstantial claim - Interpretationreasoning
Bipolar I would tend to be overestimated, since those patients to a larger extent would be identified by a hospital diagnosis compared to bipolar II patients.
“Thus, bipolar I would tend to be overestimated, since those patients to a larger extent would be identified by a hospital diagnosis compared to bipolar II patients.”
Quote in the paperNot a substantial claim - Interpretationown data
Persons with bipolar disorder had a slightly better prognosis than people with schizophrenia.
“Persons with bipolar disorder had a slightly better prognosis than people with schizophrenia, as only men in Finland with schizophrenia had overlapping confidence intervals of the overall SMR with men with bipolar disorder.”
Quote in the paperSubstantial claim - Interpretationown data
The key feature of Kraepelin's dichotomization-better prognosis for persons with bipolar disorder compared to those with schizophrenia-still applies for today's patients.
“Thus, this key feature of the dichotomization still applies for today’s patients.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] J Angst, 2002, Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia, Schizophr Res source
Not checked in the free run.
- Premisecitation
Bipolar disorder patients are much less likely to be treated with antipsychotic medication.
“Also, bipolar disorder patients are much less likely to be treated with antipsychotic medication.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] M Adler, 2012, Symptoms and treatment of bipolar patients in Sweden, Int J Psychiatry Clin Pract source
Not checked in the free run.
- Premisecitation
A reduction of 11 to 20 years in life expectancy is higher than what is associated with most other risk factors for premature death such as diabetes (up to 2 years), smoking (10 years), and severe obesity (10 years).
“A reduction of 11 to 20 years in life expectancy is higher than what is associated with most other risk factors for premature death such as diabetes (up to 2 years) [45], smoking (10 years) [46], and severe obesity (10 years) [47].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [45] KC Sikdar, 2010, Diabetes and its impact on health-related quality of life: a life table analysis, Qual Life Res source
Not checked in the free run.
- cites [46] R Doll, 2005, Mortality from cancer in relation to smoking: 50 years observations on British doctors, Br J Cancer source
Not checked in the free run.
- cites [47] G Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet source
Not checked in the free run.
- May combine two claims. 19
- Classified as probably not a substantial claim. 17
May combine two claims.
FindingreasoningAlthough men and women in Finland with bipolar disorder have lower overall mortality measured by SMR than men and women with schizophrenia, the potential loss of living years is larger among persons with bipolar disorder.
“although men and women in Finland with bipolar disorder have a lower overall mortality measured by SMR than men and women with schizophrenia, the potential loss of living years are larger among persons with bipolar disorder.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll-cause mortality SMR for men with schizophrenia was 3.3 in Finland, 3.0 in Denmark, and 2.9 in Sweden.
“The SMRs for persons with schizophrenia, was even higher with a SMR for men equaling 3.3, 3.0 and 2.9 in Finland, Denmark, and Sweden, respectively, Table 1 and 2.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDuring the years 2000 to 2006, the number of deaths in all three countries that would not have occurred if individuals with a psychiatric disorder had the same mortality as the general population was 2,960 (out of 5,436 deaths, 54%) in the group of persons with bipolar disorder and 6,424 (out of 9,535 deaths, 67%) in the group of schizophrenic persons.
“During the years 2000 to 2006 the number of deaths in all three countries that would not have occurred in the hypothetical situation that the individuals with a psychiatric disorder had the same mortality as the general population was 2,960 (out of 5,436 deaths, 54%) in the group of persons with bipolar disorder and 6,424 (out of 9,535 deaths, 67%) in the group of schizophrenic persons.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
May combine two claims.
Findingown dataAll-cause mortality SMR for men with bipolar disorder was 2.8 in Finland, 2.2 in Denmark, and 2.0 in Sweden.
“All-cause mortality was high among persons with bipolar disorder, resulting in a SMR for men in Finland equaling 2.8, in Denmark 2.2, and in Sweden 2.0.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSMR for diseases of the circulatory system among persons with schizophrenia was lower than overall SMRs in Denmark and Finland, but not in Sweden.
“SMR for DCS among persons with schizophrenia was also lower than overall SMRs in Denmark and Finland, but not in Sweden.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll-cause mortality SMR for women with schizophrenia was 3.9 in Finland, 2.7 in Denmark, and 2.9 in Sweden.
“For women with schizophrenia the SMR was 3.9, 2.7 and 2.9 in Finland, Denmark, and Sweden, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll-cause mortality SMR for women with bipolar disorder was 2.5 in Finland, 2.3 in Sweden and 2.0 in Denmark.
“The SMR for women was 2.5 in Finland, 2.3 in Sweden and 2.0 in Denmark.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the Nordic countries, women and men with severe mental disorders have an approximately 15 and 20 years shorter life expectancy, respectively, than the general population.
“In the Nordic countries, women and men with severe mental disorders have an approximately 15 and 20 years shorter life expectancy, respectively, than the general population [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Wahlbeck K, Westman J, Nordentoft M, Gissler M, Laursen TM (2011) Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. bjp.bp.110.085100 [pii];<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://dx.doi.org/10.1192/bjp.bp.110.085100" xlink:type="simple">10.1192/bjp.bp.110.085100</ext-link> [doi]. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA study from Denmark showed that patients with bipolar affective disorder or schizophrenia still have an overall cardiac mortality that is higher than in the general population, and that the excess mortality tends to be even larger in the most recent calendar time period.
“A study from Denmark showed that patients with bipolar affective disorder or schizophrenia still have an overall cardiac mortality that is higher than in the general population, and that the excess mortality tends to be even larger in the most recent calendar time period [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] TM Laursen, 2011, Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006, J Psychiatr Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExcess mortality from diseases and medical conditions in persons with psychiatric disorders has been extensively reported.
“Excess mortality from diseases and medical conditions in persons with psychiatric disorders has been extensively reported [1].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] EC Harris, 1998, Excess mortality of mental disorder, Br J Psychiatry source
Not checked in the free run.
May combine two claims.
Study design and conductcitationThe Swedish Cause of Death Register contains information about all deaths in Sweden and its coding error is estimated to be only 3%.
“The Swedish Cause of Death Register contains information about all deaths in Sweden and the coding error is estimated from a sample of deaths and was only 3% [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] LA Johansson, 2000, Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics, Int J Epidemiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease.
“a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] M Nordentoft, 2013, Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in denmark, Finland and sweden, Plos One source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDiseases of the circulatory system are the most common cause of death in the general population in Western countries, including Denmark, Finland, and Sweden.
“Diseases of the circulatory system are the most common cause of death in the general population in Western countries [9], [10], including Denmark, Finland, and Sweden.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9] Laursen TM (2006) A register based epidemiological description of risk factors and outcomes for major psychiatric disorders, focusing on a comparison between bipolar affective disorder and schizophrenia. PhD thesis. Universty of Aarhus.
Not checked in the free run.
- cites [10] CH Hennekens, 2005, Schizophrenia and increased risks of cardiovascular disease, Am Heart J source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenThe study included information from 20 million individuals from three Nordic countries with complete national coverage, and more than 100,000 persons with bipolar disorder or schizophrenia.
“In a study including information from 20 million individuals from three Nordic countries with complete national coverage, and with more than 100,000 persons with bipolar disorder or schizophrenia”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe schizoaffective subgroup was not included in the analyses.
“The schizoaffective subgroup, often included in the schizophrenia group, with a generally more favourable outcome than schizophrenia, was not included in our analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenReviews have found a huge reduction in life expectancy of approximately 10 to 20 years in persons with schizophrenia.
“Reviews have found a huge reduction in life expectancy of approximately 10 to 20 years in persons with schizophrenia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOn average the excess mortality rate in people with schizophrenia resulted in an SMR equaling 2-3 and an SMR for persons with bipolar disorder equaling a little less than two.
“On average the excess mortality rate in people with schizophrenia resulted in a SMR equaling 2–3 and a SMR for persons with bipolar disorder equaling a little less than two.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31]–[41]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London, and 13 years in a Danish study made on data similar to the Danish data used in Table 3.
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [43] CK Chang, 2011, Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London, PLoS One source
Not checked in the free run.
- cites [44] TM Laursen, 2011, Life expectancy among persons with schizophrenia or bipolar affective disorder, Schizophr Res source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe explanation for the paradox is that Finnish men with bipolar disorder have a very high mortality rate in the age groups between 15 and 44 years, so a person who dies at a young age contributes many years to the potential loss of living years.
“the explanation is that e.g. Finnish men with bipolar disorder have a very high mortality rate in the age groups between 15 and 44 years: a person who dies at a young age contributes many years to the potential loss of living years, and thus this measure becomes high although SMRs are not that high.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe risk of suicide is very high in persons with schizophrenia or bipolar disorder.
“And lastly, the risk of suicide is very high [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPhysical illnesses in persons with schizophrenia or bipolar disorder are apparently treated insufficiently or diagnosed too late.
“physical illnesses in persons with schizophrenia or bipolar disorder are apparently treated insufficiently or diagnosed too late”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningPersons with schizophrenia and bipolar disorder constitute a vulnerable group of patients who need special attention.
“Persons with schizophrenia and bipolar disorder constitute a vulnerable group of patients who need special attention.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThis may create higher levels of health inequity in Finland than in Denmark or Sweden.
“This may create higher levels of health inequity in Finland than in Denmark or Sweden.”
Quote in the paperNot a substantial claim- Rests on an assumption: Health care access in Finland is compromised by a fragmented health system more dependent on employment status and income than in Denmark and Sweden.
May combine two claims.
Interpretationown dataAlthough schizophrenia and bipolar disorder are rare disorders, the extent of the increased mortality is a substantial public health problem that has not been addressed.
“it shows that although schizophrenia and bipolar disorder are rare disorders, the extent of the increased mortality is a substantial public health problem that has not been addressed.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSome antipsychotic medicine may have negative side effects, although no clear differences between different antipsychotics have been found.
“some antipsychotic medicine may have negative side effects, although no clear differences between different antipsychotics have been found”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost studies find that cardiovascular disorder is the leading cause of death in both schizophrenia and bipolar disorder.
“Most studies find that cardiovascular disorder is the leading cause of death in both disorders.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31]–[41]
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe difference in SMRs may be related to problems in health care access in Finland.
“The difference may be related to problems in health care access in Finland.”
Quote in the paperNot a substantial claim- Rests on an assumption: Health care access in Finland is compromised by a fragmented health system more dependent on employment status and income than in Denmark and Sweden.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPersons with schizophrenia and bipolar disorder tended to have an unhealthy lifestyle especially regarding diet, smoking, alcohol, and exercise.
“persons with schizophrenia and bipolar disorder tended to have an unhealthy lifestyle especially regarding diet, smoking, alcohol, and exercise”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationIn a recent study from Stockholm County, around 30% of persons with bipolar disorder treated at a specialized affective disorder unit were medicated with antipsychotics, while in schizophrenia almost none would be without antipsychotics, and also taking larger doses.
“In a recent study from Stockholm County, around 30% of persons with bipolar disorder treated at a specialized affective disorder unit medicated with antipsychotics [42], while in schizophrenia almost none would be without antipsychotics, and also taking larger doses.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] M Adler, 2012, Symptoms and treatment of bipolar patients in Sweden, Int J Psychiatry Clin Pract source
Not checked in the free run.
The paper relies on this without support.
The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
“The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries, and thus the reason for starting follow-up at that time point in life.”
The authors state this as an assumption.
The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
“the hypothetical situation that the individuals with a psychiatric disorder had the same mortality as the general population”
“By reducing mortality in the group of persons with schizophrenia or bipolar disorder (approximately 100,000 persons) to the level of the general population”
The paper relies on this without support.
Health care access in Finland is compromised by a fragmented health system more dependent on employment status and income than in Denmark and Sweden.
“in Finland availability is compromised by a fragmented health system, where health care access is more dependent on employment status and income level.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evidence suggests CVD is the leading cause of death in individuals with SMI.
“Evidence suggests CVD is the leading cause of death in individuals with SMI.2,27,28”
From Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014 (2017) · cites this paper as [28]
Both schizophrenia and bipolar disorder have severe negative consequences for social functioning, work ability, and lifespan.
“Indeed, both disorders have severe negative consequences for social functioning, work ability, and lifespan.”
From Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning (2025) · cites this paper as [3]
Mental illness is broadly associated with poorer physical health outcomes, epitomised by a 15- to 20-year mortality gap between individuals with serious mental illness and the general population.
“Mental illness is broadly associated with poorer physical health outcomes; the severity of which is epitomised by a 15- to 20-year mortality gap between individuals with serious mental illness and the general population [104••, 105, 106].”
From Moving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety (2018) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Swedish life expectancy is not higher for every patient group
MinorThe statement includes women with schizophrenia, but Table 3 gives them a remaining life expectancy of 50.7 years in Sweden versus 51.9 years in Finland.
“Similarly, life expectancy among persons with bipolar disorder and schizophrenia was higher in Sweden than in the other two Nordic countries.”
“| Schizophrenia | 48.8 | 16.5 | 51.9 | 15.6 | 15.6 | 50.7 | 16.9 |”
Finnish men's all-cause SMR confidence intervals do not overlap
MinorFor Finnish men, the table gives an all-cause SMR interval of 2.5-3.0 for bipolar disorder and 3.2-3.5 for schizophrenia. These intervals do not overlap, contrary to the stated exception.
“| All causes of death | 2.2 (2.0–2.3) | 770 | 2.8 (2.5–3.0) | 485 | 2.0 (1.9–2.2) | 1097 |”
“only men in Finland with schizophrenia had overlapping confidence intervals of the overall SMR with men with bipolar disorder.”
The stated DCS subgroups both include ICD code I20
MinorThe methods place I20 in both the ischaemic heart disease and miscellaneous DCS ranges, although these are presented as separate subgroups.
“ischaemic heart disease (I20–25)”
“a miscellaneous group of Chapter I (I00-I20, I26-I59, I70-I99).”
Finnish women's bipolar DCS deaths do not sum to the overall count
MinorThe listed Finnish women's bipolar-disorder DCS subgroups contain 8 ischaemic heart disease deaths, 33 cerebrovascular deaths, and 30 other DCS deaths: 71 in total, not 121. The ischaemic heart disease count of 8 is also smaller than its listed subset of 24 acute myocardial infarction deaths.
Reported 121 · recomputed 71
“| Overall DCS (I00-I99) | 1.7 (1.5–1.9) | 308 | 2.1 (1.7–2.4) | 121 | 1.8 (1.7–1.9) | 566 |”
Schizophrenia DCS SMRs are lower than all-cause SMRs in Sweden too
MinorThe paper says Sweden is an exception, yet Tables 1 and 2 report Swedish schizophrenia DCS SMRs of 2.5 for men and 2.6 for women, both below their respective all-cause SMRs of 2.9.
“SMR for DCS among persons with schizophrenia was also lower than overall SMRs in Denmark and Finland, but not in Sweden.”
“| Overall DCS | 1.8 (1.6–2.1) | 294 | 2.9 (2.6–3.1) | 471 | 2.5 (2.3–2.7) | 783 |”
Cites
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807 · see citing works
Rothman, K. J., Greenland, S. 1., & Lash, T. L. (1998) · Cited by 2,106 · see citing works
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · see citing works
The Danish Psychiatric Central Research Register
Mors, O., Perto, G. P., & Mortensen, P. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810395825 · Cited by 1,589 · see citing works
- Statistical Models for Epidemiology
Broemeling, L. D. (2013) · Chapman & Hall/CRC eBooks · doi:10.1201/b15382-9 · Cited by 1,346 · see citing works
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · see citing works
Self-citationSchizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070 · see citing works
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · cited 1× · see citing works
“In recent years, cardiac mortality has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease [11].”
BackgroundSelf-citationChang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714 · cited 1× · see citing works
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
ResultMortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 1× · see citing works
“Even in the Nordic countries with well-developed welfare systems, register based studies find continued evidence of an excess mortality [2–7].”
BackgroundSelf-citationOutcomes of Nordic mental health systems: life expectancy of patients with mental disorders
Wahlbeck, K., Westman, J., Nordentoft, M., Gissler, M., & Laursen, T. M. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.085100 · Cited by 623 · see citing works
Self-citationPhysical health disparities and mental illness: the scandal of premature mortality
Thornicroft, G. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.092718 · Cited by 573 · see citing works
Life expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518 · see citing works
Self-citationLife expectancy among persons with schizophrenia or bipolar affective disorder
Laursen, T. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.008 · Cited by 508 · see citing works
Self-citationMortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412 · see citing works
The Danish registers of causes of death.
Juel, K., & Helweg‐Larsen, K. (1999) · PubMed · Cited by 410 · see citing works
Mortality from cancer in relation to smoking: 50 years observations on British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602359 · Cited by 392 · see citing works
Laursen, T. M., Munk-Olsen, T., Nordentoft, M., & Mortensen, P. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0612 · Cited by 380 · see citing works
Self-citationMental disorders and cause-specific mortality
Joukamaa, M., HeliöVaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.6.498 · Cited by 328 · see citing works
Johansson, L. A. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.3.495 · Cited by 277 · see citing works
Laursen, T. M., Munk-Olsen, T., Agerbo, E., Gasse, C., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.61 · Cited by 271 · see citing works
Self-citationThe epidemiology of excess mortality in people with mental illness
Lawrence, D., Kisely, S., & Pais, J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005501202 · Cited by 258 · see citing works
Bradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 258 · see citing works
Lahti, R. A., & Penttilä, A. (2001) · Forensic Science International · doi:10.1016/s0379-0738(00)00300-5 · Cited by 253 · see citing works
Cardiovascular Morbidity and Mortality in Bipolar Disorder
Weiner, M., Warren, L. L., & Fiedorowicz, J. G. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300107 · Cited by 221 · see citing works
Review: Mortality in schizophrenia: a measurable clinical endpoint
Bushe, C. J., Taylor, M., & Haukka, J. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382468 · Cited by 185 · see citing works
Historical aspects of the dichotomy between manic-depressive disorders and schizophrenia
Angst, J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00328-6 · Cited by 127 · see citing works
Reproductive patterns in psychotic patients
Laursen, T. M., & Munk-Olsen, T. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.018 · Cited by 111 · see citing works
Self-citationMitchell, A. J., & Lord, O. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382056 · Cited by 108 · see citing works
Laursen, T. M., & Nordentoft, M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.027 · Cited by 93 · see citing works
Self-citationReview: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?
Wildgust, H. J., & Beary, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810384639 · Cited by 93 · see citing works
Cardiovascular aspects of antipsychotics
Raedler, T. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833f46c9 · Cited by 89 · see citing works
The paradox of premature mortality in schizophrenia: new research questions
Wildgust, H. J., Hodgson, R. E., & Beary, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382149 · Cited by 74 · see citing works
Mania and mortality: Why the excess cardiovascular risk in bipolar disorder?
Murray, D. P., Weiner, M., Prabhakar, M., & Fiedorowicz, J. G. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0072-3 · Cited by 69 · see citing works
Raza, M., Alghasham, A., Alorainy, M. S., & El-Hadiyah, T. M. (2008) · Europe PMC (PubMed Central) · Cited by 53 · see citing works
Diabetes and its impact on health-related quality of life: a life table analysis
Sikdar, K. C., Wang, P. P., MacDonald, D., & Gadag, V. G. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9641-5 · Cited by 43 · see citing works
Westman, J., Gissler, M., & Wahlbeck, K. (2012) · The European Journal of Public Health · doi:10.1093/eurpub/ckr068 · Cited by 37 · see citing works
Self-citationSignorelli, C., & Colzani, E. (2010) · BOA (University of Milano-Bicocca) · Cited by 31 · see citing works
The Concept of Attributable Risk in Epidemiological Practice
Uter, W. J. C., & Pfahlberg, A. B. (1999) · Biometrical Journal · doi:10.1002/(sici)1521-4036(199912)41:8 · Cited by 25 · see citing works
How does a history of psychiatric hospital care influence access to coronary care: a cohort study
Manderbacka, K., Arffman, M., Sund, R., Haukka, J. K., Keskimäki, I., & Wahlbeck, K. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000831 · Cited by 14 · see citing works
Self-citationLaursen, T. M. (2006) · Cited by 6 · see citing works
Self-citationSymptoms and treatment of bipolar patients in Sweden
Adler, M., Backlund, L., Edman, G., & Ösby, U. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.653377 · Cited by 3 · see citing works
Self-citationPhysical illness in persons with schizophrenia--time for action.
Munk‐Jørgensen, P. (2010) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- I Keskimäki, 1991, The accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital Discharge Register, International Journal of Health Sciences, 2, 15
- Clayton D, Hills M (1993) Statistical models in epidemiology. Oxford University.
- Breslow NE, Day NE (1987) Rates and Rate standardization. In: Heseltine E, editors. Statistical methods in cancer research. Lyon: Oxford University press. 48–82.
- Wiesler H (1954) Une me’ thode simple pour la construction de tables de mortalite’ abre’ ge’ es. Proceedings of the First World Population Conference, Rome,vol 4 United Nations, 1954.
Cited by
Sorted by citations
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115 · see citing works
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304 · see citing works
Self-citationExcess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · see citing works
Self-citationCorrell, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P. A. P. M., Taipale, H. T., et al. (2022) · World Psychiatry · doi:10.1002/wps.20994 · Cited by 717 · see citing works
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014
Hayes, J. F., Marston, L., Walters, K., King, M. B., & Osborn, D. P. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.202606 · Cited by 451 · see citing works
A systematic review and meta-analysis of premature mortality in bipolar affective disorder
Hayes, J. F., Miles, J., Walters, K., King, M., & Osborn, D. P. J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12408 · Cited by 370 · see citing works
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 347 · see citing works
Moving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety
Kandola, A., Vancampfort, D., Herring, M., Rebar, A., Hallgren, M., Firth, J., & Stubbs, B. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0923-x · Cited by 291 · see citing works
Chan, J. K. N., Correll, C. U., Wong, C. S. M., Chu, R. S. T., Fung, V. S. C., Wong, G. H. S., Lei, J. H. C., & Chang, W. C. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102294 · Cited by 256 · see citing works
Severe Mental Illness and Cardiovascular Disease
Goldfarb, M., Binder, M. D., Detraux, J., Palo, K. E. D., Munir, H., Music, S., Piña, I. L., & Ringen, P. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.017 · Cited by 250 · see citing works
Life expectancy in bipolar disorder
Kessing, L. V., Vradi, E., & Andersen, P. K. (2015) · Bipolar Disorders · doi:10.1111/bdi.12296 · Cited by 218 · see citing works
Young, S. L., Taylor, M., & Lawrie, S. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114562090 · Cited by 212 · see citing works
Antipsychotic treatment and mortality in schizophrenia.
Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., & Tiihonen, J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu164 · Cited by 208 · see citing works
Causes of decreased life expectancy over the life span in bipolar disorder
Kessing, L. V., Vradi, E., McIntyre, R. S., & Andersen, P. K. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.027 · Cited by 201 · see citing works
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187 · see citing works
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
Westman, J., Eriksson, S. V., Gissler, M., Hällgren, J., Prieto, M. L., Bobo, W. V., Frye, M. A., Erlinge, D., Alfredsson, L. S., & Ösby, U. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000166 · Cited by 163 · see citing works
Self-citationMedical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems
SayuriYamagata, A., Brietzke, E. M., Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.059 · Cited by 153 · see citing works
Chan, J. K. N., Tong, C. C. H. Y., Wong, C. S. M., Chen, E. Y. H., & Chang, W. C. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.19 · Cited by 145 · see citing works
Oakley, P., Kisely, S. R., Baxter, A. J., Harris, M., Desoe, J., Dziouba, A., & Siskind, D. J. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.019 · Cited by 142 · see citing works
Hallyburton, A. (2022) · International Journal of Mental Health Nursing · doi:10.1111/inm.13034 · Cited by 141 · see citing works
Suvisaari, J., Keinänen, J., Eskelinen, S., & Mantere, O. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0704-4 · Cited by 123 · see citing works
Biazus, T. B., Beraldi, G. H., Tokeshi, L., Rotenberg, L. D. S., Dragioti, E., Carvalho, A. F., Solmi, M., & Lafer, B. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02109-9 · Cited by 121 · see citing works
Raben, A., Marshe, V. S., Chintoh, A. F., Gorbovskaya, I., Müller, D. J., & Hahn, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00741 · Cited by 114 · see citing works
Goldstein, B. I., Baune, B. T., Bond, D. J., Chen, P., Eyler, L. T., Fagiolini, A. M., Gomes, F. A., Hájek, T., Hatch, J. K., McElroy, S. L., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12921 · Cited by 112 · see citing works
Causes of mortality in schizophrenia: an updated review of European studies
Department of Psychiatry, W. M. U., Piotrowski, P., M. Gondek, T., Department of Psychiatry, W. M. U., Królicka-Deręgowska, A., Department of Psychiatry, W. M. U., Misiak, B., Department of Genetics, W. M. U., Adamowski, T., Department of Nervous System Diseases, F. O. H. S., et al. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.108 · Cited by 107 · see citing works
“- - Mittoux et al. 2013 Denmark register N/A 2002-2008 - 38.3 (18.0-84.6) -”
BackgroundResultInfluentialLomholt, L. H., Andersen, D. V., Sejrsgaard-Jacobsen, C., Øzdemir, C. M., Graff, C., Schjerning, O., Jensen, S. E., Straszek, S. P. V., Licht, R. W., Grøntved, S., et al. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-018-0140-x · Cited by 106 · see citing works
Excess medical comorbidity and mortality across the lifespan in schizophrenia.
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.020 · Cited by 103 · see citing works
Prieto, M. L., Barboza, A. B. C., Bobo, W. V., Roger, V. L., Bellivier, F., Leboyer, M., West, C. P., & Frye, M. A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12293 · Cited by 98 · see citing works
Is it time for immunopsychiatry in psychotic disorders?
Leboyer, M., Oliveira, J., Tamouza, R., & Groc, L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4266-1 · Cited by 96 · see citing works
Heiberg, I. H., Jacobsen, B. K., Nesvåg, R., Bramness, J. G., Reichborn‐Kjennerud, T., Næss, Ø., Ystrøm, E., Hultman, C. M., & Høye, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202028 · Cited by 94 · see citing works
Jakobsen, A. S., Speyer, H., Nørgaard, H. C. B., Karlsen, M., Hjorthøj, C. R., Krogh, J., Mors, O. N., Nordentoft, M., & Toft, U. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.016 · Cited by 92 · see citing works
Self-citationÖsby, U., Westman, J., Hällgren, J., & Gissler, M. (2016) · European Journal of Public Health · doi:10.1093/eurpub/ckv245 · Cited by 92 · see citing works
Self-citationExcess Mortality in Bipolar Disorders
Miller, C. J., & Bauer, M. S. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0499-z · Cited by 91 · see citing works
Hansen, P. S., Laursen, M. F., Grøntved, S., Straszek, S. P. V., Licht, R. W., & Nielsen, R. E. (2018) · Bipolar Disorders · doi:10.1111/bdi.12684 · Cited by 79 · see citing works
Nielsen, M. Ø., Rostrup, E., Wulff, S., Glenthoj, B. Y., & Ebdrup, B. H. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2582 · Cited by 76 · see citing works
Baxter, A. J., Harris, M., Khatib, Y., Brugha, T. S., Bien, H., & Bhui, K. S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.163170 · Cited by 76 · see citing works
Kugathasan, P., Stubbs, B., Aagaard, J., Jensen, S. E., Laursen, T. M., & Nielsen, R. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13076 · Cited by 75 · see citing works
Self-citationToffol, E., Hätönen, T., Tanskanen, A. J., Lönnqvist, J. K., Wahlbeck, K., Joffe, G., Tiihonen, J., Haukka, J. K., & Partonen, T. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.055 · Cited by 74 · see citing works
Self-citationCardiovascular diseases among patients with schizophrenia
Azad, M. C., Shoesmith, W. D., Mamun, M. A., Abdullah, A. F., Naing, D. K. S., Phanindranath, M., & Turin, T. C. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.11.012 · Cited by 74 · see citing works
Cernea, S., Dima, L., Correll, C. U., & Manu, P. (2020) · Drugs · doi:10.1007/s40265-020-01393-x · Cited by 74 · see citing works
Scharf, D. M., Eberhart, N. K., Hackbarth, N. S., Horvitz-Lennon, M. V., Beckman, R., Han, B., Lovejoy, S. L., Pincus, H. A., & Burnam, M. A. (2014) · Rand health quarterly · doi:10.7249/rhq-04-03-06 · Cited by 73 · see citing works
Bioque, M., García‐Portilla, M. P., García‐Rizo, C., Cabrera, B., Lobo, A., González-Pinto, A. M., Díaz‐Caneja, C. M., Corripio, I., Vieta, E., Castro‐Fornieles, J., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.032 · Cited by 71 · see citing works
Webb, R. T., Lichtenstein, P., Larsson, H., Geddes, J. R., & Fazel, S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08899 · Cited by 70 · see citing works
Chan, J. K. N., Wong, C. S. M., Yung, N. C. L., Chen, E. Y. H., & Chang, W. C. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000305 · Cited by 67 · see citing works
Bodén, R., Molin, E., Jernberg, T., Kieler, H., Lindahl, B., & Sundström, J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12329 · Cited by 67 · see citing works
Deenik, J., Kruisdijk, F. R., Tenback, D. E., Braakman‐Jansen, A., Taal, E., Hopman-Rock, M., Beekman, A. T. F., Tak, E. C. P. M., Hendriksen, I. J. M., & van Harten, P. N. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1466-0 · Cited by 67 · see citing works
Croatto, G., Vancampfort, D., Miola, A., Olivola, M., Fiedorowicz, J. G., Firth, J., Alexinschi, O., Gaina, M. A., Makkai, V., Soares, F. C., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01770-w · Cited by 66 · see citing works
Scheewe, T. W., Jörg, F., Takken, T., Deenik, J., Vancampfort, D., BACKX, F. J. G., & Cahn, W. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00087 · Cited by 63 · see citing works
DNA Methylation and Schizophrenia: Current Literature and Future Perspective
Magwai, T., Shangase, K. B., Oginga, F. O., Chiliza, B., Mpofana, T., & Xulu, K. R. (2021) · Cells · doi:10.3390/cells10112890 · Cited by 62 · see citing works
Coello, K., Vinberg, M., Knop, F. K., Pedersen, B. K., McIntyre, R. S., Kessing, L. V., & Munkholm, K. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0142-3 · Cited by 62 · see citing works
Deenik, J., Tenback, D. E., Tak, E. C. P. M., Henkemans, O. B., Rosenbaum, S., Hendriksen, I. J. M., & van Harten, P. N. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4608-x · Cited by 60 · see citing works
Lithium treatment and cancer incidence in bipolar disorder
Martinsson, L., Westman, J., Hällgren, J., Ösby, U., & Backlund, L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12361 · Cited by 60 · see citing works
Self-citationHorsdal, H. T., Köhler‐Forsberg, O., Benros, M. E., & Gasse, C. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.04.012 · Cited by 60 · see citing works
Deenik, J., Tenback, D. E., Tak, E. C. P. M., Rutters, F., Hendriksen, I. J. M., & van Harten, P. N. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.033 · Cited by 60 · see citing works
Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder
Bai, Y., Li, C., Tsai, S., Tu, P., Chen, M., & Su, T. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1143-8 · Cited by 58 · see citing works
Higher mortality and years of potential life lost of suicide in patients with schizophrenia
Ko, Y. S., Tsai, H.-C., Chi, M. H., Su, C., Lee, I. H., Chen, P. S., Chen, K. C., & Yang, Y. K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.038 · Cited by 54 · see citing works
Fok, M. L.-Y., Stewart, R. J., Hayes, R. D., & Moran, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100979 · Cited by 52 · see citing works
Nordentoft, M., Plana‐Ripoll, O., & Laursen, T. M. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000697 · Cited by 52 · see citing works
Self-citationImpaired glucose metabolism in bipolar patients and response to mood stabilizer treatments
Steardo, L., Fabrazzo, M., Sampogna, G., Monteleone, A. M., D’Agostino, G., Monteleone, P., & Maj, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.360 · Cited by 50 · see citing works
Jackson, C., Kerssens, J. J., Fleetwood, K., Smıth, D. J., Mercer, S. W., & Wild, S. H. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.250 · Cited by 49 · see citing works
Drăgoi, A. M., Rădulescu, I. D., Pop, A. L., Năsui, B. A., Varlas, V. N., & Trifu, S. C. (2020) · Brain Sciences · doi:10.3390/brainsci10110840 · Cited by 47 · see citing works
Misiak, B., Łaczmański, Ł., Słoka, N. K., Szmida, E., Piotrowski, P., Loska, O., Ślężak, R., Kiejna, A., & Frydecka, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.077 · Cited by 46 · see citing works
Factors and their weight in reducing life expectancy in schizophrenia
Correll, C. U., Bitter, I., Hoti, F. J., Mehtälä, J., Wooller, A., Pungor, K., & Tiihonen, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.10.019 · Cited by 44 · see citing works
Talaslahti, T., Alanen, H., Hakko, H. H., Isohanni, M. K., Häkkinen, U., & Leinonen, E. V. J. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4159 · Cited by 43 · see citing works
Ribe, A. R., Vestergaard, M., Katon, W. J., Charles, M., Benros, M. E., Vanderlip, E. R., Nordentoft, M., & Laursen, T. M. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14091100 · Cited by 43 · see citing works
Self-citationCoello, K., Kjærstad, H. L., Stanislaus, S., Melbye, S. A., Faurholt‐Jepsen, M., Miskowiak, K. W., McIntyre, R. S., Vinberg, M., Kessing, L. V., & Munkholm, K. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418815987 · Cited by 43 · see citing works
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Singh, R., Stogios, N., Smith, E., Lee, J., Maksyutynska, K., Au, E., Wright, D. C., Palma, G. D., Graff‐Guerrero, A., Gerretsen, P., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221096525 · Cited by 43 · see citing works
General Medical Outcomes From the Primary and Behavioral Health Care Integration Grant Program
Scharf, D. M., Hackbarth, N. S., Eberhart, N. K., Horvitz-Lennon, M. V., Beckman, R., Han, B., Pincus, H. A., & Burnam, M. A. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500352 · Cited by 42 · see citing works
Why are somatic diseases in bipolar disorder insufficiently treated?
Nielsen, R. E., Kugathasan, P., Straszek, S. P. V., Jensen, S. E., & Licht, R. W. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0147-y · Cited by 42 · see citing works
Neurological Disorders and Risk of Arrhythmia
Bernardi, J., Aromolaran, K. A., & Aromolaran, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010188 · Cited by 40 · see citing works
Deenik, J., Tenback, D. E., Tak, E. C. P. M., Hendriksen, I. J. M., & van Harten, P. N. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.10.004 · Cited by 39 · see citing works
Beunders, A. J. M., Orhan, M., & Dols, A. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000883 · Cited by 39 · see citing works
Bartlem, K. M., Bowman, J., Freund, M., Wye, P. M., Lecathelinais, C., McElwaine, K., Wolfenden, L., Gillham, K. E., & Wiggers, J. H. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400360 · Cited by 39 · see citing works
DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder
Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2015) · Epigenomics · doi:10.2217/epi.15.5 · Cited by 39 · see citing works
Bailey, J. M., Bartlem, K. M., Wiggers, J. H., Wye, P. M., Stockings, E., Hodder, R. K., Metse, A. P., Regan, T. W., Clancy, R., Dray, J., et al. (2019) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2019.100969 · Cited by 39 · see citing works
Suetani, S., Rosenbaum, S., Scott, J. G., Curtis, J., & Ward, P. B. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015001043 · Cited by 37 · see citing works
Management of serious cardiac adverse effects of antipsychotic medications
Stoner, S. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.11.246 · Cited by 37 · see citing works
Solmi, M., Koyanagi, A., Thompson, T., Fornaro, M., Correll, C. U., & Veronese, N. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579601800077x · Cited by 36 · see citing works
Hastrup, L. H., Simonsen, E. H., Ibsen, R., Kjellberg, J., & Jennum, P. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz041 · Cited by 36 · see citing works
Central levels of tryptophan metabolites in subjects with bipolar disorder
Trepci, A., Sellgren, C. M., Pålsson, E., Brundin, L., Khanlarkhani, N., Schwieler, L., Landén, M., & Erhardt, S. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.018 · Cited by 36 · see citing works
Gene‐specific DNA methylation may mediate atypical antipsychotic‐induced insulin resistance
Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12422 · Cited by 36 · see citing works
An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder
Burghardt, K. J., Evans, S. J., Wiese, K. M., & Ellingrod, V. L. (2015) · Clinical and Translational Science · doi:10.1111/cts.12324 · Cited by 35 · see citing works
Dalton, S. O., Suppli, N. P., Ewertz, M., Kroman, N. T., Grassi, L. G., & Johansen, C. (2018) · The Breast · doi:10.1016/j.breast.2018.06.002 · Cited by 35 · see citing works
Quality of life and clinical outcomes in bipolar disorder: An 8-year longitudinal study
Khafif, T. C., Belizário, G. O., Silva, M., Gomes, B. C., & Lafer, B. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.061 · Cited by 35 · see citing works
Hindley, G., Stephenson, L., Keene, A. R., Rifkin, L., Gergel, T., & Owen, G. S. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14989.2 · Cited by 35 · see citing works
Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning
Hansen, L., Bernstorff, M., Enevoldsen, K., Kolding, S., Damgaard, J. G., Perfalk, E., Nielbo, K. L., Danielsen, A. A., & Østergaard, S. D. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4702 · Cited by 34 · see citing works
Hällgren, J., Ösby, U., Westman, J., & Gissler, M. (2018) · Scandinavian Journal of Public Health · doi:10.1177/1403494818758912 · Cited by 34 · see citing works
Self-citationKugathasan, P., Wu, H., Gaughran, F., Nielsen, R. E., Pritchard, M., Dobson, R., Stewart, R. J., & Stubbs, B. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.061 · Cited by 34 · see citing works
Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine
Falkai, P., Schmitt, A., Rosenbeiger, C. P., Maurus, I., Hattenkofer, L., Hasan, A., Malchow, B., Heim-Ohmayer, P., Halle, M., & Heitkamp, M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01360-x · Cited by 34 · see citing works
Darke, S. G., Marel, C., Mills, K. L., Ross, J. E., Slade, T. N., & Teesson, M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.010 · Cited by 33 · see citing works
Treatment following myocardial infarction in patients with schizophrenia
Attar, R., Johansen, M. B., Valentin, J. B., Aagaard, J., & Jensen, S. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189289 · Cited by 33 · see citing works
Mohamed, M., Rashid, M. O., Farooq, S., Siddiqui, N., Parwani, P. J., Shiers, D., Thamman, R., Gulati, M., Shoaib, A., Chew-Graham, C. A., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.021 · Cited by 33 · see citing works
Ali, S., Santomauro, D. F., Ferrari, A. J., & Charlson, F. (2023) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796023000045 · Cited by 33 · see citing works
Mayeli, A., LaGoy, A. D., Smagula, S. F., Wilson, J. D., Zarbo, C., Rocchetti, M., Starace, F., Zamparini, M., Casiraghi, L., Calza, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02050-x · Cited by 33 · see citing works
Foroughi, M., Medina‐Inojosa, J. R., Lopez-Jimenez, F., Saeidifard, F., Suarez, L., Stokin, G. B., Prieto, M. L., Rocca, W. A., Frye, M. A., & Morgan, R. J. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001017 · Cited by 32 · see citing works
Increased long-term mortality after myocardial infarction in patients with schizophrenia
Kugathasan, P., Laursen, T. M., Grøntved, S., Jensen, S. E., Aagaard, J., & Nielsen, R. E. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.015 · Cited by 32 · see citing works
Self-citationCuperfain, A. B., Kennedy, J. L., & Gonçalves, V. F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.022 · Cited by 31 · see citing works
Quality and Predictors of Diabetes Care Among Patients With Schizophrenia: A Danish Nationwide Study
Jørgensen, M., Mainz, J., Carinci, F., Thomsen, R. W., & Johnsen, S. P. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600460 · Cited by 31 · see citing works
Bartlem, K. M., Bowman, J., Freund, M., Wye, P. M., Barker, D., McElwaine, K., Wolfenden, L., Campbell, E. M., McElduff, P., Gillham, K. E., et al. (2015) · Implementation Science · doi:10.1186/s13012-016-0408-4 · Cited by 29 · see citing works
Walburg, F. S., van Meijel, B., Hoekstra, T., Kol, J., Pape, L. M., de Joode, J. W., van Tulder, M., & Adriaanse, M. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1566 · Cited by 27 · see citing works
- Authors
- Laursen, T. M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Nordentoft, M.
- Affiliations
- Aarhus University (DK)
- Finnish Institute for Health and Welfare (FI)
- Karolinska Institutet (SE)
- University of Copenhagen (DK)
- Corresponding author
- Laursen, Thomas Munk
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-06-24
- Volume
- 8
- Issue
- 6
- Pages
- e67133
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3691116
- OpenAlex
- W2063598898
- Semantic Scholar
- 6de46ba13d1d5cdb71f0637d20707d4c3c6bde53
- Cited by
- 313
- References
- 43
- Citations by year
- 2026: 16 · 2025: 9 · 2024: 24 · 2023: 23 · 2022: 24 · 2021: 28 · 2020: 24 · 2019: 37 · 2018: 28 · 2017: 31 · 2016: 31 · 2015: 19 · 2014: 18 · 2013: 1
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Stanley Medical Research Institute
- Lundbeckfonden (R155-2012-11280)
- H. Lundbeck A/S
- Medical Research Council (MR/K006525/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Keywords
- bipolar disorder, schizophrenia, circulatory diseases, cardiovascular mortality, excess mortality, life expectancy, standardized mortality ratio, mental illness, Nordic countries, Denmark, Sweden, Finland
- MeSH terms
- Bipolar Disorder, Cardiovascular Diseases, Cardiovascular System, Cause of Death, Female, Humans, Life Expectancy, Male, Scandinavian and Nordic Countries, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review